MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Bus route 32T to operate on weekends during food festivaL

  • Gov’t tenders viaduct project near Areia Preta

  • Taipa Lunar New Year market stalls all sold

  • Londoner and MGM Cotai capture fifth of gaming revenue

  • Non-gaming investment commitments reach MOP130.5 billion as guidance fund begins operating

  • MGM properties win gold, silver in Greater Bay Area housing awards

Business
Home›Business›Samsung looks beyond smartphones to next-gen biologics

Samsung looks beyond smartphones to next-gen biologics

By -
Wednesday, May 17, 2017
109
0

A worker mops the floor of a bioreactor hall at the Samsung Biologics Co. plant 3 under construction in the Songdo district in Incheon

The Samsung brand is best known for its smartphones and wide-screen TVs. Yet behind the scenes, the conglomerate is also making a name as a contract manufacturer of complex medicines to treat diseases like cancer.

On a piece of reclaimed land along the western coast of South Korea, Samsung BioLogics Co. is building a USD740 million factory that will give it the capacity to become the No. 1 producer by volume of a class of drugs called biologics, many of which are derived from mammal cells.

The Samsung group diversified into the pharmaceutical sector in 2011. Now, it’s mobilizing its expertise in semiconductor making and engineering know-how to make the way biologics are produced on behalf of Big Pharma more efficient. The market for biologic medicines, which are used for everything from cancer to arthritis, is projected to exceed $223.7 billion by 2021, according to a Bloomberg Intelligence analysis.

Being a force in biologics is crucial to Samsung – and South Korea. Galaxy smartphones and other consumer electronics face intense competition from Apple Inc. and Chinese brands such as Huawei Technologies Co., and the chaebol is grappling with the arrest of de facto leader Jay Y. Lee in a scandal that brought down the country’s former president. Meanwhile, the broader economy needs new industries as shipbuilding and heavy manufacturing slow.

If the past 40 years of global economic growth were fueled by technology, said Kim Tae-han, chief executive officer of Samsung BioLogics, the next will be fueled by where that converges with health care.

Biologic drugs are grown from cells. That necessitates a more complex manufacturing process than typical pills – a mixture of chemicals – but makes biologics more effective and capable of being targeted toward certain diseases.

Samsung already is a contract manufacturer for some blockbuster drugs, including for Switzerland’s Roche Holding AG and the U.S.’s Bristol-Myers Squibb Co. It will take three years for the factory to ramp up to full capacity after being completed this year and opening at the end of 2018.

Globally, the drug industry produces 4 million liters of biologic drugs a year, and that’s projected to double by 2030. With its new plant, Samsung BioLogics is positioning itself to double its market share. Shares are up 24 percent this year to 187,000 won. That compares with a 13 percent increase in the benchmark Kospi index.

Samsung and other companies in the sector have benefited from the Korean government’s support of biopharmaceutical businesses. The Incheon Free Economic Zone offered Samsung BioLogics the factory land for 50 years without rent, the company said. New President Moon Jae-in railed against the chaebol during his campaign, but Samsung said in an email it expected him to boost the biopharmaceutical and health-care industries.

Nevertheless, Samsung faces some formidable competitors, who are also expanding. Switzerland’s Lonza Group AG and Germany’s Boehringer Ingelheim GmbH have long histories in the biologics contract manufacturing business, and Japan’s Fujifilm Holdings Corp. also entered the business. MDT/Bloomberg

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

Previous Article

Corporate bits | MGM Macau introduces new ...

Next Article

Goldman Sachs builds China financial-stress index

Related articles More from author

  • Business

    Greece, creditors at loggerheads as debt deadline looms 

    Friday, June 26, 2015
    By -
  • Business

    Yuan advances for third day as producer prices signal recovery

    Tuesday, April 12, 2016
    By -
  • Business

    Vegas gambler’s pal recounts innocent start to insider plot

    Thursday, March 23, 2017
    By -
  • Business

    PROJECT POKER : Finite energy, infinite possibilities

    Friday, July 25, 2014
    By -
  • Business

    Hong Kong stocks eke out gain as casinos gain, developers drop

    Thursday, August 11, 2016
    By -
  • Business

    Two princes and an emirate: Record Da Vinci spurs many ‘buyers’

    Monday, December 11, 2017
    By -

Leave a reply Cancel reply

You must be logged in to post a comment.

  • Business

    Corporate Bits | MGM holds recruitment fair for Cotai property

  • Features

    News of the World | Probe will test technology to detect ripples in space-time

  • Business

    The St. Regis Macao presents festive culinary delights

DAILY EDITION

Thursday, November 19, 2026 – edition no. 5079
Thursday, November 19, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Thursday, November 19, 2026

    Bus route 32T to operate on weekends during food festivaL

  • Thursday, November 19, 2026

    Gov’t tenders viaduct project near Areia Preta

  • Thursday, November 19, 2026

    Taipa Lunar New Year market stalls all sold

  • Thursday, November 19, 2026

    Londoner and MGM Cotai capture fifth of gaming revenue

  • Thursday, November 19, 2026

    Non-gaming investment commitments reach MOP130.5 billion as guidance fund begins operating

  • Thursday, November 19, 2026

    MGM properties win gold, silver in Greater Bay Area housing awards

  • Thursday, November 19, 2026

    Domingo, Carreras to headline Macau opera gala in February

  • Thursday, November 19, 2026

    Reigning champions and F3 contenders field showdown in Macau

  • Thursday, November 19, 2026

    Three former winners battle to regain Macau crown

  • Thursday, November 19, 2026

    Local team to approach GP with ‘humility and realistic expectations’

Extra Times

Extra TimesHeadlinesTaste of Edesia

Three chefs. One horizon. Six Michelin stars

There are moments when separate culinary philosophies align so precisely that the result transcends mere menu-making. At Chef Tam’s Seasons, Wynn Palace, three two-Michelin-starred titans—each ranked among Asia’s 50 Best ...
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • The Twelve25 × La Vie exchange

    By -
    Friday, November 13, 2026
  • A fiery milestone: Feng Wei Ju’s 20th anniversary tribute to Starworld Macau

    By Irene Sam, MDT
    Friday, November 6, 2026
  • In ‘I Play Rocky,’ a middleweight crowd-pleaser about the making of a classic

    By MDT/AP
    Friday, November 6, 2026
  • Recent

  • Popular

  • Bus route 32T to operate on weekends during food festivaL

    By -
    Thursday, November 19, 2026
  • Gov’t tenders viaduct project near Areia Preta

    By -
    Thursday, November 19, 2026
  • Taipa Lunar New Year market stalls all sold

    By -
    Thursday, November 19, 2026
  • Londoner and MGM Cotai capture fifth of gaming revenue

    By Nadia Shaw, MDT
    Thursday, November 19, 2026
  • Non-gaming investment commitments reach MOP130.5 billion as guidance fund begins operating

    By Yuki Lei, MDT
    Thursday, November 19, 2026
  • MGM properties win gold, silver in Greater Bay Area housing awards

    By -
    Thursday, November 19, 2026
  • Domingo, Carreras to headline Macau opera gala in February

    By -
    Thursday, November 19, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d